id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02392572
|
42:67:treatment,78:100:cancer,,125:141:treatment,,171:190:treatment
|
Patients receiving any other standard or investigational treatment for their hematologic malignancy within past 2 weeks for cytotoxic agents or at least 5 half-lives for noncytotoxic agents
| 3
|
[
"Patients",
"receiving",
"any",
"other",
"standard",
"or",
"investigational",
"treatment",
"for",
"their",
"hematologic",
"malignancy",
"within",
"past",
"2",
"weeks",
"for",
"cytotoxic",
"agents",
"or",
"at",
"least",
"5",
"half-lives",
"for",
"noncytotoxic",
"agents"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
3,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01319474
|
75:84:chronic_disease
|
Be suspected by the referring medical provider to have a first episode of acute DVT of the lower extremities
| 3
|
[
"Be",
"suspected",
"by",
"the",
"referring",
"medical",
"provider",
"to",
"have",
"a",
"first",
"episode",
"of",
"acute",
"DVT",
"of",
"the",
"lower",
"extremities"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02503722
|
17:21:treatment,50:61:treatment,106:122:chronic_disease,127:146:chronic_disease
|
obtained from 3 ECGs, using the screening clinic ECG machine derived QTc value, or history of congenital long QT syndrome, or torsades de pointes)
| 3
|
[
"obtained",
"from",
"3",
"ECGs",
",",
"using",
"the",
"screening",
"clinic",
"ECG",
"machine",
"derived",
"QTc",
"value",
",",
"or",
"history",
"of",
"congenital",
"long",
"QT",
"syndrome",
",",
"or",
"torsades",
"de",
"pointes",
")"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
2,
0
] |
NCT01220583
|
,,35:46:treatment,
|
Hemoglobin ≥ 8.0 g/dL (the use of transfusion or other intervention to achieve hemoglobin ≥ 8.0 g/dL is acceptable)
| 3
|
[
"Hemoglobin",
"≥",
"8.0",
"g/dL",
"(",
"the",
"use",
"of",
"transfusion",
"or",
"other",
"intervention",
"to",
"achieve",
"hemoglobin",
"≥",
"8.0",
"g/dL",
"is",
"acceptable",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01384513
|
35:45:cancer,62:73:cancer,99:108:treatment
|
Patients with evidence of another malignancy, exclusive of a skin cancer that requires only local treatment, should not be enrolled on this protocol
| 3
|
[
"Patients",
"with",
"evidence",
"of",
"another",
"malignancy",
",",
"exclusive",
"of",
"a",
"skin",
"cancer",
"that",
"requires",
"only",
"local",
"treatment",
",",
"should",
"not",
"be",
"enrolled",
"on",
"this",
"protocol"
] |
[
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03016871
|
,,,112:125:chronic_disease,168:191:chronic_disease,196:225:treatment,235:243:chronic_disease,254:285:chronic_disease
|
Myocardial infarction within 6 months prior to enrollment or New York Heart Association (NYHA) class III or IV heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities
| 3
|
[
"Myocardial",
"infarction",
"within",
"6",
"months",
"prior",
"to",
"enrollment",
"or",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"class",
"III",
"or",
"IV",
"heart",
"failure",
",",
"uncontrolled",
"angina",
",",
"severe",
"uncontrolled",
"ventricular",
"arrhythmias",
",",
"or",
"electrocardiographic",
"evidence",
"of",
"acute",
"ischemia",
"or",
"active",
"conduction",
"system",
"abnormalities"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
1,
1,
0,
0,
2,
0,
0,
2,
2,
2
] |
NCT02332668
|
1:17:chronic_disease
|
Hepatitis B or C
| 3
|
[
"Hepatitis",
"B",
"or",
"C"
] |
[
2,
2,
2,
2
] |
NCT02595866
|
8:23:chronic_disease
|
active angina pectoris
| 3
|
[
"active",
"angina",
"pectoris"
] |
[
0,
2,
2
] |
NCT02514915
|
1:20:cancer
|
Primary brain tumor
| 3
|
[
"Primary",
"brain",
"tumor"
] |
[
3,
3,
3
] |
NCT02553447
|
1:14:chronic_disease
|
Hypercalcemia
| 3
|
[
"Hypercalcemia"
] |
[
2
] |
NCT02417701
|
10:25:chronic_disease
|
unstable angina pectoris
| 3
|
[
"unstable",
"angina",
"pectoris"
] |
[
0,
2,
2
] |
NCT02310464
|
9:29:treatment
|
Another investigational drug
| 3
|
[
"Another",
"investigational",
"drug"
] |
[
0,
1,
1
] |
NCT02513485
|
67:89:treatment,,116:128:treatment,,153:165:treatment,197:210:treatment,242:249:treatment,253:299:treatment,,327:334:treatment,,362:374:treatment,402:418:treatment,450:461:treatment,
|
Chronic use of agents known to affect the immune system including glucocorticoid therapy within the past 6 months, methotrexate within the past 1 year, chemotherapy of any kind (past or present), immunotherapy of any kind (past or present), aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) (within the past 2 weeks), statins (within the past 1 month), vaccinations (within the past 2 weeks), topical steroids (within the past 2 weeks), and antibiotics (within the past two weeks) unless otherwise approved by principal investigator or PI's designee
| 3
|
[
"Chronic",
"use",
"of",
"agents",
"known",
"to",
"affect",
"the",
"immune",
"system",
"including",
"glucocorticoid",
"therapy",
"within",
"the",
"past",
"6",
"months",
",",
"methotrexate",
"within",
"the",
"past",
"1",
"year",
",",
"chemotherapy",
"of",
"any",
"kind",
"(",
"past",
"or",
"present",
")",
",",
"immunotherapy",
"of",
"any",
"kind",
"(",
"past",
"or",
"present",
")",
",",
"aspirin",
"or",
"non-steroidal",
"anti-inflammatory",
"drugs",
"(",
"NSAIDs",
")",
"(",
"within",
"the",
"past",
"2",
"weeks",
")",
",",
"statins",
"(",
"within",
"the",
"past",
"1",
"month",
")",
",",
"vaccinations",
"(",
"within",
"the",
"past",
"2",
"weeks",
")",
",",
"topical",
"steroids",
"(",
"within",
"the",
"past",
"2",
"weeks",
")",
",",
"and",
"antibiotics",
"(",
"within",
"the",
"past",
"two",
"weeks",
")",
"unless",
"otherwise",
"approved",
"by",
"principal",
"investigator",
"or",
"PI",
"'s",
"designee"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01660607
|
1:28:treatment
|
Prior myeloablative therapy
| 3
|
[
"Prior",
"myeloablative",
"therapy"
] |
[
1,
1,
1
] |
NCT02911831
|
25:37:treatment,102:118:chronic_disease,120:131:chronic_disease,133:149:chronic_disease,151:162:chronic_disease,164:175:chronic_disease,177:189:chronic_disease,191:212:chronic_disease,216:229:chronic_disease
|
Patients presenting for hysterectomy for any benign indication including but not limited to abnormal uterine bleeding, menorrhagia, uterine fibroids, adenomyosis, pelvic pain, dysmenorrhea, pelvic organ prolapse or endometriosis
| 3
|
[
"Patients",
"presenting",
"for",
"hysterectomy",
"for",
"any",
"benign",
"indication",
"including",
"but",
"not",
"limited",
"to",
"abnormal",
"uterine",
"bleeding",
",",
"menorrhagia",
",",
"uterine",
"fibroids",
",",
"adenomyosis",
",",
"pelvic",
"pain",
",",
"dysmenorrhea",
",",
"pelvic",
"organ",
"prolapse",
"or",
"endometriosis"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2
] |
NCT02393157
|
1:30:cancer
|
Diffuse Large B-Cell Lymphoma
| 3
|
[
"Diffuse",
"Large",
"B-Cell",
"Lymphoma"
] |
[
3,
3,
3,
3
] |
NCT02500381
|
1:34:treatment,36:52:treatment,54:70:treatment,74:90:treatment,
|
Previous treatment with SMT C1100, PRO045 (BMN 045), PRO053 (BMN 053) or PRO051 (BMN 051) within 24 weeks prior to Week 1
| 3
|
[
"Previous",
"treatment",
"with",
"SMT",
"C1100",
",",
"PRO045",
"(",
"BMN",
"045",
")",
",",
"PRO053",
"(",
"BMN",
"053",
")",
"or",
"PRO051",
"(",
"BMN",
"051",
")",
"within",
"24",
"weeks",
"prior",
"to",
"Week",
"1"
] |
[
1,
1,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02349867
|
26:63:treatment
|
Concomitant use of other histone deacetylase (HDAC) inhibitors
| 3
|
[
"Concomitant",
"use",
"of",
"other",
"histone",
"deacetylase",
"(",
"HDAC",
")",
"inhibitors"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02146924
|
46:65:chronic_disease,70:93:chronic_disease,111:123:chronic_disease
|
ot requiring pressor support, no symptomatic cardiac arrhythmias, no acute coronary syndrome, or uncontrolled hypertension
| 3
|
[
"ot",
"requiring",
"pressor",
"support",
",",
"no",
"symptomatic",
"cardiac",
"arrhythmias",
",",
"no",
"acute",
"coronary",
"syndrome",
",",
"or",
"uncontrolled",
"hypertension"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
2
] |
NCT02577367
|
,57:69:treatment,71:126:treatment,131:155:treatment
|
Started on Enteral feeding within 3 days of enrollment: tube feeding, Percutaneous Endoscopic Gastrostomy or PEG tube feeding, or Jejunostomy tube feeding
| 3
|
[
"Started",
"on",
"Enteral",
"feeding",
"within",
"3",
"days",
"of",
"enrollment",
":",
"tube",
"feeding",
",",
"Percutaneous",
"Endoscopic",
"Gastrostomy",
"or",
"PEG",
"tube",
"feeding",
",",
"or",
"Jejunostomy",
"tube",
"feeding"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
1,
1,
1
] |
NCT03059355
|
15:31:cancer
|
subjects with prior malignancy must be disease free for 3 years
| 3
|
[
"subjects",
"with",
"prior",
"malignancy",
"must",
"be",
"disease",
"free",
"for",
"3",
"years"
] |
[
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02252432
|
1:25:chronic_disease
|
Congestive heart failure
| 3
|
[
"Congestive",
"heart",
"failure"
] |
[
2,
2,
2
] |
NCT02140255
|
55:58:treatment
|
Other than the exception in the next bullet point for NVP, each agent in the regimen must be taken daily from the date of initiation
| 3
|
[
"Other",
"than",
"the",
"exception",
"in",
"the",
"next",
"bullet",
"point",
"for",
"NVP",
",",
"each",
"agent",
"in",
"the",
"regimen",
"must",
"be",
"taken",
"daily",
"from",
"the",
"date",
"of",
"initiation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03120728
|
12:41:chronic_disease
|
history of superficial venous thrombosis not associated with catheter
| 3
|
[
"history",
"of",
"superficial",
"venous",
"thrombosis",
"not",
"associated",
"with",
"catheter"
] |
[
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02257424
|
12:36:chronic_disease,48:69:chronic_disease,74:89:chronic_disease,92:112:treatment,117:125:treatment,
|
History of acute coronary syndromes (including myocardial infarction and unstable angina), coronary angioplasty, or stenting within 6 months prior to randomization
| 3
|
[
"History",
"of",
"acute",
"coronary",
"syndromes",
"(",
"including",
"myocardial",
"infarction",
"and",
"unstable",
"angina",
")",
",",
"coronary",
"angioplasty",
",",
"or",
"stenting",
"within",
"6",
"months",
"prior",
"to",
"randomization"
] |
[
0,
0,
2,
1,
1,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02465034
|
14:31:chronic_disease
|
History of a major psychiatric diagnosis
| 3
|
[
"History",
"of",
"a",
"major",
"psychiatric",
"diagnosis"
] |
[
0,
0,
0,
2,
2,
0
] |
NCT01822522
|
29:42:treatment,35:42:treatment,,103:115:treatment
|
complete wound healing from prior surgery must be confirmed at least 28 days before the first dose of cabozantinib irrespective of the time from surgery
| 3
|
[
"complete",
"wound",
"healing",
"from",
"prior",
"surgery",
"must",
"be",
"confirmed",
"at",
"least",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"cabozantinib",
"irrespective",
"of",
"the",
"time",
"from",
"surgery"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01684397
|
23:47:treatment
|
Subjects currently on anti-coagulation therapy
| 3
|
[
"Subjects",
"currently",
"on",
"anti-coagulation",
"therapy"
] |
[
0,
0,
0,
1,
1
] |
NCT02272556
|
7:29:chronic_disease
|
Known Neurological Disorders
| 3
|
[
"Known",
"Neurological",
"Disorders"
] |
[
0,
2,
2
] |
NCT02518594
|
1:16:chronic_disease
|
Placenta previa, because of risk of bleeding and high potential for indicated preterm birth
| 3
|
[
"Placenta",
"previa",
",",
"because",
"of",
"risk",
"of",
"bleeding",
"and",
"high",
"potential",
"for",
"indicated",
"preterm",
"birth"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02791646
|
1:24:cancer
|
metastases to the brain
| 3
|
[
"metastases",
"to",
"the",
"brain"
] |
[
3,
3,
3,
3
] |
NCT00594217
|
,,106:109:chronic_disease,114:120:cancer,122:129:cancer,134:152:cancer
|
women with a history of any disorders that may potentially be complicated by hormonal treatment, such as DVT and breast, ovarian, or endometrial cancer
| 3
|
[
"women",
"with",
"a",
"history",
"of",
"any",
"disorders",
"that",
"may",
"potentially",
"be",
"complicated",
"by",
"hormonal",
"treatment",
",",
"such",
"as",
"DVT",
"and",
"breast",
",",
"ovarian",
",",
"or",
"endometrial",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
3,
0,
3,
0,
0,
3,
3
] |
NCT02143830
|
35:49:chronic_disease
|
Patients must have a diagnosis of Fanconi anemia
| 3
|
[
"Patients",
"must",
"have",
"a",
"diagnosis",
"of",
"Fanconi",
"anemia"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02355535
|
5:12:treatment,,43:52:treatment,82:113:treatment
|
Had surgery within 4 weeks prior to study treatment except for minor procedures (hepatic biliary stent placement is allowed)
| 3
|
[
"Had",
"surgery",
"within",
"4",
"weeks",
"prior",
"to",
"study",
"treatment",
"except",
"for",
"minor",
"procedures",
"(",
"hepatic",
"biliary",
"stent",
"placement",
"is",
"allowed",
")"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT01950234
|
,,55:57:chronic_disease
|
Male or female patients with a confirmed diagnosis of MS by McDonald criteria
| 3
|
[
"Male",
"or",
"female",
"patients",
"with",
"a",
"confirmed",
"diagnosis",
"of",
"MS",
"by",
"McDonald",
"criteria"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0
] |
NCT02989805
|
1:21:chronic_disease
|
Cognitive impairment
| 3
|
[
"Cognitive",
"impairment"
] |
[
2,
2
] |
NCT01787409
|
23:39:cancer
|
patients with typical Burkitt lymphoma are not eligible
| 3
|
[
"patients",
"with",
"typical",
"Burkitt",
"lymphoma",
"are",
"not",
"eligible"
] |
[
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT01943851
|
12:36:chronic_disease,48:63:chronic_disease,68:89:chronic_disease,92:112:treatment,117:125:treatment,
|
History of acute coronary syndromes (including unstable angina and myocardial infarction), coronary angioplasty, or stenting within the past 3 months
| 3
|
[
"History",
"of",
"acute",
"coronary",
"syndromes",
"(",
"including",
"unstable",
"angina",
"and",
"myocardial",
"infarction",
")",
",",
"coronary",
"angioplasty",
",",
"or",
"stenting",
"within",
"the",
"past",
"3",
"months"
] |
[
0,
0,
2,
1,
1,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02793583
|
1:50:treatment
|
Prior Allogeneic hematologic stem cell transplant
| 3
|
[
"Prior",
"Allogeneic",
"hematologic",
"stem",
"cell",
"transplant"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT03048448
|
1:26:chronic_disease,,,
|
Severe hepatic impairment (Group 2): Child-Pugh Class C (10-15 points
| 3
|
[
"Severe",
"hepatic",
"impairment",
"(",
"Group",
"2",
")",
":",
"Child-Pugh",
"Class",
"C",
"(",
"10-15",
"points"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02553265
|
15:34:chronic_disease,36:42:chronic_disease,58:61:treatment
|
Patients with atrial fibrillation, angina or significant ECG abnormality
| 3
|
[
"Patients",
"with",
"atrial",
"fibrillation",
",",
"angina",
"or",
"significant",
"ECG",
"abnormality"
] |
[
0,
0,
2,
2,
0,
2,
0,
0,
1,
0
] |
NCT02579265
|
27:31:allergy_name,34:37:allergy_name,40:44:allergy_name,49:63:allergy_name
|
Known hypersensitivity to fish-, egg-, soya- or peanut protein or to any of the active substances or excipients
| 3
|
[
"Known",
"hypersensitivity",
"to",
"fish-",
",",
"egg-",
",",
"soya-",
"or",
"peanut",
"protein",
"or",
"to",
"any",
"of",
"the",
"active",
"substances",
"or",
"excipients"
] |
[
0,
0,
0,
4,
0,
4,
0,
4,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02184520
|
8:25:cancer,15:25:cancer,54:73:cancer,82:106:cancer,132:160:treatment,
|
Has an active malignancy defined as a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least 5 years
| 3
|
[
"Has",
"an",
"active",
"malignancy",
"defined",
"as",
"a",
"history",
"of",
"any",
"invasive",
"malignancy",
"(",
"except",
"non-melanoma",
"skin",
"cancer",
")",
",",
"unless",
"he/she",
"has",
"been",
"treated",
"with",
"curative",
"intent",
"and",
"there",
"has",
"been",
"no",
"clinical",
"signs",
"or",
"symptoms",
"of",
"the",
"malignancy",
"for",
"at",
"least",
"5",
"years"
] |
[
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02177292
|
12:30:treatment
|
History of prior chemotherapy
| 3
|
[
"History",
"of",
"prior",
"chemotherapy"
] |
[
0,
0,
1,
1
] |
NCT02076906
|
28:69:treatment
|
The last dose of all other local palliative (limited port) radiation
| 3
|
[
"The",
"last",
"dose",
"of",
"all",
"other",
"local",
"palliative",
"(",
"limited",
"port",
")",
"radiation"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02706249
|
14:35:chronic_disease,,,,
|
Uncontrolled arterial hypertension (systolic blood pressure > 200mmHg, diastolic >110mmHg)
| 3
|
[
"Uncontrolled",
"arterial",
"hypertension",
"(",
"systolic",
"blood",
"pressure",
">",
"200mmHg",
",",
"diastolic",
">",
"110mmHg",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01703949
|
34:45:cancer
|
Documented expression of CD30 on tumor cells
| 3
|
[
"Documented",
"expression",
"of",
"CD30",
"on",
"tumor",
"cells"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT02514070
|
29:38:treatment,40:49:treatment,54:64:treatment,
|
Subjects being treated with tamoxifen, estrogens, or progestins that have not been stable for >4 weeks
| 3
|
[
"Subjects",
"being",
"treated",
"with",
"tamoxifen",
",",
"estrogens",
",",
"or",
"progestins",
"that",
"have",
"not",
"been",
"stable",
"for",
">",
"4",
"weeks"
] |
[
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02606045
|
6:24:chronic_disease
|
past thrombotic disease
| 3
|
[
"past",
"thrombotic",
"disease"
] |
[
0,
2,
2
] |
NCT02070549
|
14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,142:157:chronic_disease,167:177:chronic_disease,182:201:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 3
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02148796
|
1:30:chronic_disease
|
gastrointestinal malformation
| 3
|
[
"gastrointestinal",
"malformation"
] |
[
2,
2
] |
NCT01595529
|
16:38:treatment
|
A child taking antibiotic prophylaxis for any reason
| 3
|
[
"A",
"child",
"taking",
"antibiotic",
"prophylaxis",
"for",
"any",
"reason"
] |
[
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT01777035
|
1:23:chronic_disease,25:48:chronic_disease,50:66:chronic_disease
|
Traumatic brain injury, multiple limb fractures, pelvic fractures
| 3
|
[
"Traumatic",
"brain",
"injury",
",",
"multiple",
"limb",
"fractures",
",",
"pelvic",
"fractures"
] |
[
2,
2,
2,
0,
2,
2,
2,
0,
2,
2
] |
NCT02367196
|
,,69:91:treatment
|
Prior Red blood cell (RBC) transfusion < 3 months prior to starting CC-90002 (Part A only)
| 3
|
[
"Prior",
"Red",
"blood",
"cell",
"(",
"RBC",
")",
"transfusion",
"<",
"3",
"months",
"prior",
"to",
"starting",
"CC-90002",
"(",
"Part",
"A",
"only",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02266784
|
74:78:chronic_disease
|
(Inattentive Symptoms, Hyperactive-Impulsive Symptoms, Total Symptoms or ADHD Index) on both the Self-Report
| 3
|
[
"(",
"Inattentive",
"Symptoms",
",",
"Hyperactive-Impulsive",
"Symptoms",
",",
"Total",
"Symptoms",
"or",
"ADHD",
"Index",
")",
"on",
"both",
"the",
"Self-Report"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02131805
|
67:79:treatment
|
BCC/SCC in region adjacent to or overlapping with region of prior radiotherapy
| 3
|
[
"BCC/SCC",
"in",
"region",
"adjacent",
"to",
"or",
"overlapping",
"with",
"region",
"of",
"prior",
"radiotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02424968
|
28:38:chronic_disease
|
patients with a history of acute GVHD overall grade II based on skin only involvement or upper gastrointestinal (GI) tract involvement only
| 3
|
[
"patients",
"with",
"a",
"history",
"of",
"acute",
"GVHD",
"overall",
"grade",
"II",
"based",
"on",
"skin",
"only",
"involvement",
"or",
"upper",
"gastrointestinal",
"(",
"GI",
")",
"tract",
"involvement",
"only"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02846532
|
30:43:chronic_disease
|
Known clinically significant liver disease
| 3
|
[
"Known",
"clinically",
"significant",
"liver",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02620579
|
1:24:chronic_disease
|
neurological impairment of the in the upper-extremity (determined by loss of sensation, muscle weakness, and reflex changes)
| 3
|
[
"neurological",
"impairment",
"of",
"the",
"in",
"the",
"upper-extremity",
"(",
"determined",
"by",
"loss",
"of",
"sensation",
",",
"muscle",
"weakness",
",",
"and",
"reflex",
"changes",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01880567
|
17:20:cancer,22:35:treatment,,54:95:treatment
|
Newly diagnosed MCL: Major surgery within 4 weeks or vaccination with live attenuated vaccines within 4 weeks of the first dose of study drug
| 3
|
[
"Newly",
"diagnosed",
"MCL",
":",
"Major",
"surgery",
"within",
"4",
"weeks",
"or",
"vaccination",
"with",
"live",
"attenuated",
"vaccines",
"within",
"4",
"weeks",
"of",
"the",
"first",
"dose",
"of",
"study",
"drug"
] |
[
0,
0,
3,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02465060
|
15:25:chronic_disease,
|
patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial
| 3
|
[
"patients",
"with",
"infections",
"unlikely",
"to",
"be",
"resolved",
"within",
"2",
"weeks",
"following",
"screening",
"should",
"not",
"be",
"considered",
"for",
"the",
"trial"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01988246
|
1:23:treatment,32:41:treatment,45:67:chronic_disease,
|
Focal photocoagulation for the treatment of diabetic macular edema in the study eye within 6 months of the pre-operative baseline visit
| 3
|
[
"Focal",
"photocoagulation",
"for",
"the",
"treatment",
"of",
"diabetic",
"macular",
"edema",
"in",
"the",
"study",
"eye",
"within",
"6",
"months",
"of",
"the",
"pre-operative",
"baseline",
"visit"
] |
[
1,
1,
0,
0,
1,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02003690
|
13:31:chronic_disease,33:65:chronic_disease,78:109:chronic_disease
|
evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder by the K-SADS-PL, parent report, medical history, or school records
| 3
|
[
"evidence",
"of",
"mental",
"retardation",
",",
"pervasive",
"developmental",
"disorder",
",",
"or",
"organic",
"central",
"nervous",
"system",
"disorder",
"by",
"the",
"K-SADS-PL",
",",
"parent",
"report",
",",
"medical",
"history",
",",
"or",
"school",
"records"
] |
[
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02772237
|
12:22:chronic_disease,
|
A previous concussion within the last 12 months
| 3
|
[
"A",
"previous",
"concussion",
"within",
"the",
"last",
"12",
"months"
] |
[
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT03054155
|
15:41:chronic_disease
|
Patients with photosensitivity disorders
| 3
|
[
"Patients",
"with",
"photosensitivity",
"disorders"
] |
[
0,
0,
2,
2
] |
NCT00799864
|
21:25:treatment,60:63:treatment,,108:111:treatment
|
Any previous use of ARVs with the exception of single dose NVP (Cohort 1 and Cohort 2) or up to 6 weeks of AZT (Cohort 2 only) to prevent mother-to-child transmission (MTCT)
| 3
|
[
"Any",
"previous",
"use",
"of",
"ARVs",
"with",
"the",
"exception",
"of",
"single",
"dose",
"NVP",
"(",
"Cohort",
"1",
"and",
"Cohort",
"2",
")",
"or",
"up",
"to",
"6",
"weeks",
"of",
"AZT",
"(",
"Cohort",
"2",
"only",
")",
"to",
"prevent",
"mother-to-child",
"transmission",
"(",
"MTCT",
")"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01903330
|
17:29:treatment,46:55:treatment,78:90:treatment,111:123:treatment,
|
Patients taking temozolomide can start study treatment 23 days from the last temozolamide dose. For all other chemotherapy drugs, study treatment can start as long as adverse events related to their treatment is </= to Grade 1
| 3
|
[
"Patients",
"taking",
"temozolomide",
"can",
"start",
"study",
"treatment",
"23",
"days",
"from",
"the",
"last",
"temozolamide",
"dose",
".",
"For",
"all",
"other",
"chemotherapy",
"drugs",
",",
"study",
"treatment",
"can",
"start",
"as",
"long",
"as",
"adverse",
"events",
"related",
"to",
"their",
"treatment",
"is",
"<",
"/=",
"to",
"Grade",
"1"
] |
[
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00285935
|
15:21:chronic_disease,,,,,,,,,,,
|
Not currently anemic (Hct of 36-48 for females and 38-54 for males, or Hgb of 12.5-20) and has not donated blood for at least 8 weeks prior to baseline blood draw
| 3
|
[
"Not",
"currently",
"anemic",
"(",
"Hct",
"of",
"36-48",
"for",
"females",
"and",
"38-54",
"for",
"males",
",",
"or",
"Hgb",
"of",
"12.5-20",
")",
"and",
"has",
"not",
"donated",
"blood",
"for",
"at",
"least",
"8",
"weeks",
"prior",
"to",
"baseline",
"blood",
"draw"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02480036
|
1:30:treatment,
|
Previous radiopharmaceuticals (i.e, Ra-222, Sr-90, etc) within 30 days of procedure
| 3
|
[
"Previous",
"radiopharmaceuticals",
"(",
"i.e",
",",
"Ra-222",
",",
"Sr-90",
",",
"etc",
")",
"within",
"30",
"days",
"of",
"procedure"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02684201
|
22:37:chronic_disease
|
be at least one year post-amputation
| 3
|
[
"be",
"at",
"least",
"one",
"year",
"post-amputation"
] |
[
0,
0,
0,
0,
0,
2
] |
NCT03104699
|
1:13:treatment,53:62:treatment,77:86:treatment
|
Chemotherapy administered concurrently with primary radiation (e.g., weekly cisplatin)
| 3
|
[
"Chemotherapy",
"administered",
"concurrently",
"with",
"primary",
"radiation",
"(",
"e.g.",
",",
"weekly",
"cisplatin",
")"
] |
[
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0
] |
NCT02520011
|
9:33:treatment,35:52:treatment,57:70:treatment,72:83:treatment,,167:176:treatment
|
Require concomitant chemotherapy, radiation therapy, or immunotherapy. Hydroxyurea is allowed up to the evening before starting (but not within 12 hours) of starting treatment on either arm
| 3
|
[
"Require",
"concomitant",
"chemotherapy",
",",
"radiation",
"therapy",
",",
"or",
"immunotherapy",
".",
"Hydroxyurea",
"is",
"allowed",
"up",
"to",
"the",
"evening",
"before",
"starting",
"(",
"but",
"not",
"within",
"12",
"hours",
")",
"of",
"starting",
"treatment",
"on",
"either",
"arm"
] |
[
0,
1,
1,
0,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01648751
|
39:62:chronic_disease,71:86:treatment,88:111:chronic_disease,124:130:chronic_disease
|
Contraindication to hormone use (i.e. thromboembolic disorder, use of anti-coagulants, coronary artery disease, history of stroke)
| 3
|
[
"Contraindication",
"to",
"hormone",
"use",
"(",
"i.e",
".",
"thromboembolic",
"disorder",
",",
"use",
"of",
"anti-coagulants",
",",
"coronary",
"artery",
"disease",
",",
"history",
"of",
"stroke",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
2,
2,
2,
0,
0,
0,
2,
0
] |
NCT02544880
|
1:29:treatment,
|
sildenafil citrate (Viagra®) ≤15-days prior to (intended) enrollment
| 3
|
[
"sildenafil",
"citrate",
"(",
"Viagra®",
")",
"≤15-days",
"prior",
"to",
"(",
"intended",
")",
"enrollment"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01449149
|
,,,,,,171:183:treatment
|
Women of child-bearing potential as long as she agrees to use a recognized method of birth control (e.g. oral contraceptive , IUD, condoms or other barrier methods etc.) Hysterectomy or menopause must be clinically documented
| 3
|
[
"Women",
"of",
"child-bearing",
"potential",
"as",
"long",
"as",
"she",
"agrees",
"to",
"use",
"a",
"recognized",
"method",
"of",
"birth",
"control",
"(",
"e.g",
".",
"oral",
"contraceptive",
",",
"IUD",
",",
"condoms",
"or",
"other",
"barrier",
"methods",
"etc",
".",
")",
"Hysterectomy",
"or",
"menopause",
"must",
"be",
"clinically",
"documented"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02908841
|
1:21:treatment
|
Vaginal hysterectomy
| 3
|
[
"Vaginal",
"hysterectomy"
] |
[
1,
1
] |
NCT02409810
|
1:28:chronic_disease
|
Acute myocardial infarction
| 3
|
[
"Acute",
"myocardial",
"infarction"
] |
[
2,
2,
2
] |
NCT02469519
|
10:26:chronic_disease
|
Clinical chorioamnionitis
| 3
|
[
"Clinical",
"chorioamnionitis"
] |
[
0,
2
] |
NCT01822522
|
1:12:treatment,14:26:treatment,28:40:treatment,42:54:treatment,56:67:treatment,69:81:treatment
|
Antifungals: itraconazole, ketoconazole, voriconazole, fluconazole, posaconazole
| 3
|
[
"Antifungals",
":",
"itraconazole",
",",
"ketoconazole",
",",
"voriconazole",
",",
"fluconazole",
",",
"posaconazole"
] |
[
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02495168
|
16:26:treatment
|
Able to inhale study drug properly
| 3
|
[
"Able",
"to",
"inhale",
"study",
"drug",
"properly"
] |
[
0,
0,
0,
1,
1,
0
] |
NCT02143726
|
15:28:treatment,
|
No history of major surgery ≤ 28 days of registration
| 3
|
[
"No",
"history",
"of",
"major",
"surgery",
"≤",
"28",
"days",
"of",
"registration"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02883387
|
1:16:chronic_disease
|
Hepatic failure
| 3
|
[
"Hepatic",
"failure"
] |
[
2,
2
] |
NCT03116230
|
7:17:chronic_disease,18:25:treatment,27:42:chronic_disease,79:117:chronic_disease,,,
|
Prior ACL injury/surgery, meniscus injury/surgery, and/or physician-diagnosed medial compartment knee osteoarthritis (KL grade 1-3)
| 3
|
[
"Prior",
"ACL",
"injury/surgery",
",",
"meniscus",
"injury/surgery",
",",
"and/or",
"physician-diagnosed",
"medial",
"compartment",
"knee",
"osteoarthritis",
"(",
"KL",
"grade",
"1-3",
")"
] |
[
0,
2,
1,
0,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT03108820
|
20:42:chronic_disease
|
have a significant traumatic brain injury
| 3
|
[
"have",
"a",
"significant",
"traumatic",
"brain",
"injury"
] |
[
0,
0,
0,
2,
2,
2
] |
NCT01940757
|
1:14:chronic_disease,
|
Severe asthma as defined by the need for daily use of inhalers or emergency clinic visit or hospitalization within 6 months of the volunteer's expected Day 0 of the study
| 3
|
[
"Severe",
"asthma",
"as",
"defined",
"by",
"the",
"need",
"for",
"daily",
"use",
"of",
"inhalers",
"or",
"emergency",
"clinic",
"visit",
"or",
"hospitalization",
"within",
"6",
"months",
"of",
"the",
"volunteer",
"'s",
"expected",
"Day",
"0",
"of",
"the",
"study"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01280994
|
26:46:chronic_disease
|
Subject has no diagnosed pulmonary conditions
| 3
|
[
"Subject",
"has",
"no",
"diagnosed",
"pulmonary",
"conditions"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02245841
|
39:53:chronic_disease
|
Patients with a history of or current gastric ulcers
| 3
|
[
"Patients",
"with",
"a",
"history",
"of",
"or",
"current",
"gastric",
"ulcers"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02162810
|
21:48:treatment
|
Patients undergoing proximal hypospadias repair
| 3
|
[
"Patients",
"undergoing",
"proximal",
"hypospadias",
"repair"
] |
[
0,
0,
1,
1,
1
] |
NCT01547429
|
17:35:chronic_disease
|
Patients with a retinal detachment or a family history of retinal detachment
| 3
|
[
"Patients",
"with",
"a",
"retinal",
"detachment",
"or",
"a",
"family",
"history",
"of",
"retinal",
"detachment"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01941316
|
,70:108:treatment
|
Subjects that progressed during or within one month of completion of first-line platinum-based chemotherapy
| 3
|
[
"Subjects",
"that",
"progressed",
"during",
"or",
"within",
"one",
"month",
"of",
"completion",
"of",
"first-line",
"platinum-based",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01918644
|
5:34:treatment
|
Any prior external beam radiation will be evaluated to determine radiation field overlaps and appropriateness of protocol radiation
| 3
|
[
"Any",
"prior",
"external",
"beam",
"radiation",
"will",
"be",
"evaluated",
"to",
"determine",
"radiation",
"field",
"overlaps",
"and",
"appropriateness",
"of",
"protocol",
"radiation"
] |
[
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00819208
|
,,137:143:cancer
|
Stage III disease, defined as having at least one pathologically confirmed positive lymph node or one pathologically confirmed positive tumour deposit
| 3
|
[
"Stage",
"III",
"disease",
",",
"defined",
"as",
"having",
"at",
"least",
"one",
"pathologically",
"confirmed",
"positive",
"lymph",
"node",
"or",
"one",
"pathologically",
"confirmed",
"positive",
"tumour",
"deposit"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02461927
|
9:31:chronic_disease,
|
Current substance use disorder by DSM-5 in the past 3 months (except alcohol, tobacco, or cannabis)
| 3
|
[
"Current",
"substance",
"use",
"disorder",
"by",
"DSM-5",
"in",
"the",
"past",
"3",
"months",
"(",
"except",
"alcohol",
",",
"tobacco",
",",
"or",
"cannabis",
")"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03088072
|
36:46:treatment,50:59:treatment
|
A need for on-going treatment with ticagrelor or prasugrel
| 3
|
[
"A",
"need",
"for",
"on-going",
"treatment",
"with",
"ticagrelor",
"or",
"prasugrel"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02515110
|
65:79:cancer
|
Positive sentinel lymph node biopsy (ie, demonstrating invasive adenocarcinoma)
| 3
|
[
"Positive",
"sentinel",
"lymph",
"node",
"biopsy",
"(",
"ie",
",",
"demonstrating",
"invasive",
"adenocarcinoma",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT01666665
|
14:23:allergy_name
|
Allergies to Metformin
| 3
|
[
"Allergies",
"to",
"Metformin"
] |
[
0,
0,
4
] |
NCT02344355
|
11:25:treatment,37:47:treatment,,96:116:treatment
|
High-dose ascorbate acid is a known CYP450 3A4 inducer, which results in lower serum levels of antiretroviral drugs
| 3
|
[
"High-dose",
"ascorbate",
"acid",
"is",
"a",
"known",
"CYP450",
"3A4",
"inducer",
",",
"which",
"results",
"in",
"lower",
"serum",
"levels",
"of",
"antiretroviral",
"drugs"
] |
[
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02410707
|
1:28:chronic_disease
|
Cardiopulmonary instability
| 3
|
[
"Cardiopulmonary",
"instability"
] |
[
2,
2
] |
NCT03028350
|
8:12:treatment,16:33:treatment,40:50:treatment,,
|
Use of oral or systemic steroids (e.g. prednisone or equivalent) > 20 mg daily in the last four weeks before starting treatment
| 3
|
[
"Use",
"of",
"oral",
"or",
"systemic",
"steroids",
"(",
"e.g",
".",
"prednisone",
"or",
"equivalent",
")",
">",
"20",
"mg",
"daily",
"in",
"the",
"last",
"four",
"weeks",
"before",
"starting",
"treatment"
] |
[
0,
0,
1,
0,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02762773
|
29:51:treatment,53:60:treatment,64:81:treatment
|
Patients who will require a vertical skin incision, Maylard or Cherney incisions
| 3
|
[
"Patients",
"who",
"will",
"require",
"a",
"vertical",
"skin",
"incision",
",",
"Maylard",
"or",
"Cherney",
"incisions"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.